Pre-treatment with idelalisib markedly reduces Rituximab infusion-related reactions and infusion interruptions in patients with CLL Meeting Abstract
| Authors: | Hillmen, P.; Furman, R. R.; Coutre, S. E.; Sharman, J. P.; Pagel, J. M.; Barrientos, J. C.; Zelenetz, A. D.; Kipps, T. J.; Flinn, I.; Ghia, P.; Eradat, H. A.; Lamanna, N.; Coiffier, B.; Pettitt, A.; Ye, W.; Jahn, T. M.; Dubowy, R.; O'Brien, S. M.; Hallek, M. J.; Cheson, B. D. |
| Abstract Title: | Pre-treatment with idelalisib markedly reduces Rituximab infusion-related reactions and infusion interruptions in patients with CLL |
| Meeting Title: | 19th Congress of the European Hematology Association (EHA) |
| Journal Title: | Haematologica |
| Volume: | 99 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2014 Jun 12-15 |
| Meeting Location: | Milan, Italy |
| ISSN: | 0390-6078 |
| Publisher: | Ferrata Storti Foundation |
| Date Published: | 2014-06-01 |
| Start Page: | 55 |
| Language: | English |
| ACCESSION: | WOS:000342830900137 |
| PROVIDER: | wos |
| PMCID: | PMC4060398 |
| Notes: | Meeting Abstract: P236 -- 19th Congress of the European-Hematology-Association -- JUN 12-15, 2014 -- Milan, ITALY -- Source: Wos |
MSK Authors
-
767Zelenetz
Related MSK Work